vs
Side-by-side financial comparison of Everus Construction Group, Inc. (ECG) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $1.0B, roughly 1.5× Everus Construction Group, Inc.). Everus Construction Group, Inc. runs the higher net margin — 5.5% vs 4.4%, a 1.0% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs 32.8%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $23.5M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 27.1%).
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
ECG vs ONC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $1.5B |
| Net Profit | $55.3M | $66.5M |
| Gross Margin | 11.6% | 90.5% |
| Operating Margin | 6.8% | 12.4% |
| Net Margin | 5.5% | 4.4% |
| Revenue YoY | 33.2% | 32.8% |
| Net Profit YoY | 60.4% | 143.8% |
| EPS (diluted) | $1.09 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.0B | $1.5B | ||
| Q3 25 | $986.8M | $1.4B | ||
| Q2 25 | $921.5M | $1.3B | ||
| Q1 25 | $826.6M | $1.1B | ||
| Q4 24 | $759.6M | $1.1B | ||
| Q3 24 | $761.0M | $1.0B | ||
| Q2 24 | $703.4M | $929.2M | ||
| Q1 24 | $625.7M | $751.7M |
| Q4 25 | $55.3M | $66.5M | ||
| Q3 25 | $57.0M | $124.8M | ||
| Q2 25 | $52.8M | $94.3M | ||
| Q1 25 | $36.7M | $1.3M | ||
| Q4 24 | $34.5M | $-151.9M | ||
| Q3 24 | $41.8M | $-121.3M | ||
| Q2 24 | $39.0M | $-120.4M | ||
| Q1 24 | $28.2M | $-251.2M |
| Q4 25 | 11.6% | 90.5% | ||
| Q3 25 | 12.6% | 86.1% | ||
| Q2 25 | 13.0% | 87.5% | ||
| Q1 25 | 11.2% | 85.2% | ||
| Q4 24 | 11.4% | 85.8% | ||
| Q3 24 | 11.8% | 83.0% | ||
| Q2 24 | 12.6% | 85.1% | ||
| Q1 24 | 11.9% | 83.4% |
| Q4 25 | 6.8% | 12.4% | ||
| Q3 25 | 7.3% | 11.5% | ||
| Q2 25 | 7.9% | 6.7% | ||
| Q1 25 | 6.2% | 1.0% | ||
| Q4 24 | 6.1% | -7.0% | ||
| Q3 24 | 7.1% | -12.0% | ||
| Q2 24 | 7.3% | -11.5% | ||
| Q1 24 | 6.2% | -34.8% |
| Q4 25 | 5.5% | 4.4% | ||
| Q3 25 | 5.8% | 8.8% | ||
| Q2 25 | 5.7% | 7.2% | ||
| Q1 25 | 4.4% | 0.1% | ||
| Q4 24 | 4.5% | -13.5% | ||
| Q3 24 | 5.5% | -12.1% | ||
| Q2 24 | 5.5% | -13.0% | ||
| Q1 24 | 4.5% | -33.4% |
| Q4 25 | $1.09 | $0.05 | ||
| Q3 25 | $1.11 | $0.08 | ||
| Q2 25 | $1.03 | $0.06 | ||
| Q1 25 | $0.72 | $0.00 | ||
| Q4 24 | $0.68 | $-0.10 | ||
| Q3 24 | $0.82 | $-0.09 | ||
| Q2 24 | $0.76 | $-0.09 | ||
| Q1 24 | $0.55 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $4.5B |
| Total DebtLower is stronger | $281.5M | $836.4M |
| Stockholders' EquityBook value | $629.8M | $4.4B |
| Total Assets | $1.7B | $8.2B |
| Debt / EquityLower = less leverage | 0.45× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $4.5B | ||
| Q3 25 | — | $4.0B | ||
| Q2 25 | — | $2.8B | ||
| Q1 25 | — | $2.5B | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | $553.0K | $2.7B | ||
| Q2 24 | — | $2.6B | ||
| Q1 24 | — | $2.8B |
| Q4 25 | $281.5M | $836.4M | ||
| Q3 25 | $285.1M | — | ||
| Q2 25 | $288.6M | — | ||
| Q1 25 | $292.1M | — | ||
| Q4 24 | $295.6M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $629.8M | $4.4B | ||
| Q3 25 | $573.0M | $4.1B | ||
| Q2 25 | $514.4M | $3.8B | ||
| Q1 25 | $460.2M | $3.5B | ||
| Q4 24 | $422.6M | $3.3B | ||
| Q3 24 | $453.3M | $3.4B | ||
| Q2 24 | $490.0M | $3.4B | ||
| Q1 24 | $464.3M | $3.4B |
| Q4 25 | $1.7B | $8.2B | ||
| Q3 25 | $1.6B | $7.6B | ||
| Q2 25 | $1.5B | $6.3B | ||
| Q1 25 | $1.4B | $5.8B | ||
| Q4 24 | $1.3B | $5.9B | ||
| Q3 24 | $1.3B | $5.8B | ||
| Q2 24 | — | $5.7B | ||
| Q1 24 | — | $5.7B |
| Q4 25 | 0.45× | 0.19× | ||
| Q3 25 | 0.50× | — | ||
| Q2 25 | 0.56× | — | ||
| Q1 25 | 0.63× | — | ||
| Q4 24 | 0.70× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $48.2M | $417.3M |
| Free Cash FlowOCF − Capex | $23.5M | $379.8M |
| FCF MarginFCF / Revenue | 2.3% | 25.4% |
| Capex IntensityCapex / Revenue | 2.4% | 2.5% |
| Cash ConversionOCF / Net Profit | 0.87× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $90.0M | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $48.2M | $417.3M | ||
| Q3 25 | $76.2M | $402.6M | ||
| Q2 25 | $25.3M | $263.6M | ||
| Q1 25 | $7.1M | $44.1M | ||
| Q4 24 | — | $75.2M | ||
| Q3 24 | $78.9M | $188.4M | ||
| Q2 24 | — | $-95.6M | ||
| Q1 24 | $21.9M | $-308.6M |
| Q4 25 | $23.5M | $379.8M | ||
| Q3 25 | $65.7M | $354.5M | ||
| Q2 25 | $12.3M | $219.8M | ||
| Q1 25 | $-11.4M | $-12.3M | ||
| Q4 24 | — | $-17.3M | ||
| Q3 24 | $60.9M | $54.7M | ||
| Q2 24 | — | $-205.5M | ||
| Q1 24 | $12.6M | $-465.1M |
| Q4 25 | 2.3% | 25.4% | ||
| Q3 25 | 6.7% | 25.1% | ||
| Q2 25 | 1.3% | 16.7% | ||
| Q1 25 | -1.4% | -1.1% | ||
| Q4 24 | — | -1.5% | ||
| Q3 24 | 8.0% | 5.5% | ||
| Q2 24 | — | -22.1% | ||
| Q1 24 | 2.0% | -61.9% |
| Q4 25 | 2.4% | 2.5% | ||
| Q3 25 | 1.1% | 3.4% | ||
| Q2 25 | 1.4% | 3.3% | ||
| Q1 25 | 2.2% | 5.0% | ||
| Q4 24 | — | 8.2% | ||
| Q3 24 | 2.4% | 13.3% | ||
| Q2 24 | — | 11.8% | ||
| Q1 24 | 1.5% | 20.8% |
| Q4 25 | 0.87× | 6.28× | ||
| Q3 25 | 1.34× | 3.22× | ||
| Q2 25 | 0.48× | 2.79× | ||
| Q1 25 | 0.19× | 34.71× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.89× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.77× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ECG
| Commercial | $594.5M | 59% |
| Utility | $203.5M | 20% |
| Industrial | $82.8M | 8% |
| Institutional | $66.1M | 7% |
| Service And Other | $28.4M | 3% |
| Transportation | $24.2M | 2% |
| Renewables | $19.8M | 2% |
ONC
Segment breakdown not available.
